至今,GenScript的服务及产品已被Cell, Nature, Science, PNAS等1300多家生物医药类杂志引用近万次,处于行业领先水平。NIH、哈佛、耶鲁、斯坦福、普林斯顿、杜克大学等约400家全球著名机构使用GenScript的基因合成、多肽服务、抗体服务和蛋白服务等成功地发表科研成果,再次证明GenScript 有能力帮助业内科学家Make research easy.

Thrombus-targeted nanoparticles for thrombin-triggered thrombolysis and local inflammatory microenvironment regulation

J Control Release. 2021-06; 
Huijuan Zhang, Hongyan Qu, Qingqing He, Linyu Gao, Hongling Zhang, Yongfu Wang, Zhenzhong Zhang, Lin Hou
Products/Services Used Details Operation
Peptide Synthesis … Glycine-Phenylalanine-Glycine-Glycine (GGLVPRGFGG, pep, ≥ 95%) and scrambled-peptide sequence: Glycine-Glycine-Leucine-Valine-Glycine-Arginine-Proline-Phenylalanine-Glycine- Glycine (GGLVGRPFGG, pep', ≥ 95%) were synthesized by GenScript Biotechnology Co … Get A Quote

摘要

Thrombus related diseases seriously threaten human's health and life. The drawbacks of thrombolytic drugs, such as poor targeting ability and unexpected bleeding complications limit their clinical application. Thus, targeted delivery and controlled release of drugs at local thrombus sites to achieve efficient thrombolysis is an urgent event to be resolved. Herein, we developed an intelligent system MnO/uPA@pep-Fuco for precise thrombolysis and thrombus inflammatory microenvironment remodeling. MnO/uPA@pep-Fuco exhibited an excellent thrombus targeting ability via the high affinity of fucoidan (Fuco) for P-selectin overexpressed by activated platelets. And then pep-Fuco modified onto the surface of mesopore coul... More

关键词

Collaborative thrombolysis therapy, MnO(2), Thrombin-responsive, Thrombus targeting